* Provides solutions for analyzing brain atrophy and white matter hyperintensities, as well as mo...
* Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Secu...
* Introduces key products including an integrated brain imaging analysis solution for Alzheimer's...
* Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial d...
* Former Vice President and Chief Technology Officer of RadNet, one of the largest outpatient ima...
* Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Ne...
* Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-...
* Introduced brain-imaging analysis products, including Neurophet AQUA AD, which enables monitori...
* Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables mon...
* Expert in sales and commercial strategy…Ex-Philips and previously served as Chief Commercial Of...
* Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diag...
- Clinical study conducted at the Dementia Research Centre, Nanyang Technological University,Singap...
* Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzh...
* Showcased brain imaging analysis products such as Neurophet AQUA AD, capable of monitoring side...
* Highlight brain imaging analysis solutions, including 'Neurophet AQUA AD', which monitors side ...
* Co-CEO Jake Junkil Been joins Industry Collaboration Session to present Neurophet's brain imagi...
- Showcased core technology and products for personalized tDCS at the conference inKobe, Japan - P...
* Demonstrates MS Analysis Technology, Recently Secured FDA 510(k) Clearance * Introduces 'Neuro...
* New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensi...
- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology a...
